XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Balance (in shares) at Dec. 31, 2019   3,930,669    
Balance at Dec. 31, 2019 $ 66,994 $ 106,170 $ (38,773) $ (403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (3,819)   (3,819)  
Unrealized holding loss on available-for-sale securities, net of tax (115)     (115)
Comprehensive (loss) income (3,934)   (3,819) (115)
Share-based compensation expense 159 $ 159    
Vesting of restricted stock (in shares)   12,903    
Balance (in shares) at Dec. 31, 2020   3,943,572    
Balance at Dec. 31, 2020 63,219 $ 106,329 (42,592) (518)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 5,094   5,094  
Unrealized holding loss on available-for-sale securities, net of tax (1,119)     (1,119)
Comprehensive (loss) income 3,975   5,094 (1,119)
Share-based compensation expense $ 150 $ 150    
Vesting of restricted stock (in shares)   12,920    
Balance (in shares) at Dec. 31, 2021 3,956,492 3,956,492    
Balance at Dec. 31, 2021 $ 67,344 $ 106,479 (37,498) (1,637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 6,161   6,161  
Unrealized holding loss on available-for-sale securities, net of tax (14,008)     (14,008)
Comprehensive (loss) income (7,847)   6,161 (14,008)
Share-based compensation expense $ 86 $ 86    
Vesting of restricted stock (in shares)   8,694    
Balance (in shares) at Dec. 31, 2022 3,965,186 3,965,186    
Balance at Dec. 31, 2022 $ 59,583 $ 106,565 $ (31,337) $ (15,645)